Clinical progress note: Hepatitis A virus.
Where this comes from
- Record sourced from PubMed, PMID 40932297.
- Also identified by DOI 10.1002/jhm.70171 and PMC identifier 12954352.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi-state outbreaks have demonstrated that HAV can re-emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk factors. Continued investment in prevention, particularly vaccination and surveillance, is essential to prevent resurgence. Hospitalization offers a critical opportunity to address these gaps and provide equitable protection for at-risk populations.
Medical subject headings
- Hepatitis A
- Hepatitis A Vaccines
- Hepatitis A virus
- Disease Outbreaks